About ThermoGenesis Corp.
ThermoGenesis Corp. (http://www.thermogenesis.com) is a leader in developing and manufacturing automated blood processing systems and disposable products that enable the manufacture, preservation and delivery of cell and tissue therapy products. These products include:
-- The BioArchive(R) System, an automated cryogenic device, is used by
cord blood stem cell banks in more than 25 countries for
cryopreserving and archiving cord blood stem cell units for transplant.
GE Healthcare is the non-exclusive global distribution partner for the
-- AXP(TM) AutoXpress Platform (AXP(TM)) is a proprietary, semi-automated
device and companion sterile blood processing disposable for
harvesting stem cells from cord blood in a functionally closed system.
GE Healthcare is the exclusive global distribution partner for the AXP
-- The CryoSeal(R) FS System, an automated device and companion sterile
blood processing disposable, is used to prepare fibrin sealants from
plasma in about an hour. We received FDA clearance to market the
CryoSeal FS System in liver resection surgeries in July 2007. The
CryoSeal FS System has received the CE-Mark. From a marketing
perspective, the CE Mark is the European equivalent to an FDA approval,
in that it allows sales of the product throughout the European
community. Asahi Medical is the exclusive distributor for the
CryoSeal System in Japan and the Company markets through independent
distributors in Europe and South Ameri
|SOURCE ThermoGenesis Corp.|
Copyright©2007 PR Newswire.
All rights reserved